Daniel K. Spiegelman is CFO & VP at BIOMARIN PHARMACEUTICAL INC (BMRN). They have made 28 open-market trades across 5 companies since 2006, most recently 2025-05-29.
CIK 0001238403
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $32K since 2015, against 27 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MYGN | SELL · 10b5-1 | 2024-06-03 | 2024-06-04 | $22.05 | $334K | +3.1% | +10.6% | +22.0% |
| MYGN | SELL | 2023-06-02 | 2023-06-02 | $23.01 | $398K | -0.1% | +1.6% | -21.9% |
| MYGN | SELL | 2022-06-06 | 2022-06-06 | $19.25 | $124K | -10.6% | +3.3% | +16.0% |
| MYGN | SELL | 2021-06-17 | 2021-06-17 | $30.52 | $192K | +1.3% | -0.4% | +8.8% |
| MYGN | SELL | 2021-05-28 | 2021-06-01 | $28.99 | $414K | +6.2% | +11.9% | +28.0% |
| BMRN | SELL | 2019-04-01 | 2019-04-03 | $89.00 | $1.2M | -0.4% | -8.8% | -8.8% |
| BMRN | SELL · 10b5-1 | 2019-03-27 | 2019-03-29 | $90.00 | $9K | +3.7% | -3.7% | -5.6% |
| BMRN | SELL | 2018-06-22 | 2018-06-26 | $99.00 | $990K | +6.4% | +9.4% | +4.4% |
| BMRN | SELL | 2018-04-23 | 2018-04-25 | $82.15 | $1.8M | +6.2% | +12.9% | +23.3% |
| BMRN | SELL | 2017-03-16 | 2017-03-17 | $91.96 | $366K | -1.5% | -0.3% | -0.5% |
| BMRN | SELL | 2017-03-06 | 2017-03-08 | $93.32 | $430K | -0.2% | -2.5% | -0.6% |
| BMRN | SELL | 2017-02-28 | 2017-03-02 | $94.07 | $3.3M | -1.7% | -7.1% | -6.0% |
| BMRN | SELL | 2017-01-09 | 2017-01-10 | $90.00 | $450K | -7.3% | +1.5% | -1.8% |
| BMRN | SELL | 2016-11-09 | 2016-11-14 | $90.61 | $1.8M | -3.2% | -6.9% | -1.1% |
| BMRN | SELL | 2016-08-01 | 2016-08-03 | $99.33 | $397K | -9.1% | -6.5% | -19.2% |
| RLYP | SELL | 2016-06-07 | 2016-06-08 | $19.31 | $20K | -8.7% | +5.8% | N/A |
| BMRN | SELL | 2016-06-06 | 2016-06-08 | $89.14 | $294K | +0.4% | +9.2% | +14.1% |
| BMRN | SELL | 2016-05-31 | 2016-06-02 | $89.79 | $2.2M | -11.1% | -12.4% | +3.0% |
| BMRN | SELL | 2016-05-23 | 2016-05-25 | $87.07 | $656K | -2.9% | -12.5% | +12.9% |
| BMRN | SELL | 2016-03-02 | 2016-03-02 | $86.12 | $796K | -3.3% | -4.8% | +0.8% |
| BMRN | SELL · 10b5-1 | 2015-11-16 | 2015-11-18 | $104.30 | $2.1M | -18.2% | +2.1% | -27.8% |
| BMRN | SELL · 10b5-1 | 2015-06-05 | 2015-06-08 | $122.30 | $202K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2015-05-29 | 2015-06-03 | $124.73 | $689K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL | 2015-05-27 | 2017-10-13 | $130.00 | $4.4M | -10.9% | -14.8% | -5.4% |
| BMRN | SELL · 10b5-1 | 2015-05-18 | 2015-05-28 | $130.00 | $4.4M | -18.2% | +2.1% | +2.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.